{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:29:36Z","timestamp":1787898576591,"version":"build-2784847793"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"am","delay-in-days":285,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002529"],"award-info":[{"award-number":["UL1TR002529"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003187","name":"NSF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006975","name":"Indiana Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008523","name":"Center for Clinical and Translational Science, University of Illinois at Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008523","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["PFI TT IIP-2016516"],"award-info":[{"award-number":["PFI TT IIP-2016516"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Chemistry"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.forc.2023.100475","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T03:03:53Z","timestamp":1675047833000},"page":"100475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Validated method for the analysis of 22 illicit drugs and their metabolites via liquid chromatography tandem mass spectrometry (LC-MS\/MS) in illicit drug samples collected in Chicago, IL"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1817-604X","authenticated-orcid":false,"given":"Heather D.","family":"Whitehead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1217-0050","authenticated-orcid":false,"given":"Kathleen L.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Robison-Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Ellen Mackesy-Amiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio D.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3968-8044","authenticated-orcid":false,"given":"Marya","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forc.2023.100475_b0005","unstructured":"Drug Overdose Deaths in the U.S. Top 100,000 Annually, in, United States Centers for Disease Control and Prevention, Online, 2021."},{"key":"10.1016\/j.forc.2023.100475_b0010","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.forc.2023.100475_b0015","unstructured":"Overdose Death Rates, in, National Institute on Drug Abuse, Online. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates, 2021."},{"key":"10.1016\/j.forc.2023.100475_b0020","doi-asserted-by":"crossref","first-page":"108329","DOI":"10.1016\/j.drugalcdep.2020.108329","article-title":"Addressing opioid overdose deaths: The vision for the HEALing communities study","volume":"217","author":"Chandler","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forc.2023.100475_b0025","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/add.15734","article-title":"Drug checking services for people who use drugs: a systematic review","volume":"117","author":"Maghsoudi","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.forc.2023.100475_b0030","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/dta.3022","article-title":"Implementing an integrated multi-technology platform for drug checking: Social, scientific, and technological considerations","volume":"13","author":"Wallace","year":"2021","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forc.2023.100475_b0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12954-017-0179-5","article-title":"An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services","volume":"14","author":"Harper","year":"2017","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.forc.2023.100475_b0040","article-title":"Drug Checking as Strategy for Harm Reduction in Recreational Contests: Evaluation of Two Different Drug Analysis Methodologies","volume":"12","author":"Fregonese","year":"2021","journal-title":"Front. Psych."},{"key":"10.1016\/j.forc.2023.100475_b0045","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.drugpo.2019.09.017","article-title":"Adulterants and altruism: A qualitative investigation of \u201cdrug checkers\u201d in North America","volume":"74","author":"Palamar","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.forc.2023.100475_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.103037","article-title":"Suitability of infrared spectroscopy for drug checking in harm reduction centres","volume":"88","author":"Goncalves","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.forc.2023.100475_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.vibspec.2021.103243","article-title":"Fentanyl quantification using portable infrared absorption spectroscopy. A framework for community drug checking","volume":"114","author":"Ramsay","year":"2021","journal-title":"Vibrational Spectroscopy"},{"key":"10.1016\/j.forc.2023.100475_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.103065","article-title":"Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs","volume":"90","author":"Bergh","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.forc.2023.100475_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108976","article-title":"Results from a mobile drug checking pilot program using three technologies in Chicago, IL, USA","volume":"228","author":"Karch","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.forc.2023.100475_b0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugpo.2018.08.007","article-title":"Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States","volume":"63","author":"Peiper","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.forc.2023.100475_b0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugpo.2018.09.009","article-title":"Use of rapid fentanyl test strips among young adults who use drugs","volume":"61","author":"Krieger","year":"2018","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.forc.2023.100475_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102900","article-title":"Agency in the fentanyl era: Exploring the utility of fentanyl test strips in an opaque drug market","volume":"84","author":"Weicker","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.forc.2023.100475_b0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12954-018-0276-0","article-title":"Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study","volume":"16","author":"Goldman","year":"2019","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.forc.2023.100475_b0090","first-page":"38","article-title":"A Practical Guide to Urine Drug Monitoring","volume":"35","author":"Raouf","year":"2018","journal-title":"Fed. Pract."},{"key":"10.1016\/j.forc.2023.100475_b0095","doi-asserted-by":"crossref","first-page":"16308","DOI":"10.1021\/acs.analchem.1c03310","article-title":"Fast Quantitative LC-MS\/MS Determination of Illicit Substances in Solid and Liquid Unknown Seized Samples","volume":"93","author":"Merone","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.forc.2023.100475_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.talo.2022.100105","article-title":"Fast LC\u2013MS\/MS screening method for the evaluation of drugs, illicit drugs, and other compounds in biological matrices","volume":"5","author":"Merone","year":"2022","journal-title":"Talanta Open"},{"key":"10.1016\/j.forc.2023.100475_b0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/dta.2744","article-title":"Pitfalls in drug testing by hyphenated low- and high-resolution mass spectrometry","volume":"12","author":"Maurer","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forc.2023.100475_b0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.forsciint.2010.07.037","article-title":"Screening for illicit drugs on Euro banknotes by LC\u2013MS\/MS","volume":"206","author":"Wimmer","year":"2011","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forc.2023.100475_b0115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jat\/29.4.234","article-title":"Application of direct urine LC-MS-MS analysis for screening of novel substances in drug abusers","volume":"29","author":"Nordgren","year":"2005","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forc.2023.100475_b0120","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jms.4431","article-title":"Paper spray mass spectrometry: A new drug checking tool for harm reduction in the opioid overdose crisis","volume":"54","author":"Vandergrift","year":"2019","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.forc.2023.100475_b0125","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/dar.13370","article-title":"A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry","volume":"41","author":"Borden","year":"2022","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.forc.2023.100475_b0130","unstructured":"2021 Chicago Mid-Year Opioid Report, in, Chicago Department of Public Health, 2021."},{"key":"10.1016\/j.forc.2023.100475_b0135","unstructured":"2020 Chicago Opioid Overdose Data Brief, in, Chicago Department of Public Health, 2021."},{"key":"10.1016\/j.forc.2023.100475_b0140","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/1556-4029.14318","article-title":"idPAD: Paper Analytical Device for Presumptive Identification of Illicit Drugs","volume":"65","author":"Lockwood","year":"2020","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forc.2023.100475_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102661","article-title":"An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples","volume":"77","author":"Green","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.forc.2023.100475_b0150","series-title":"Comprehensive LC\/MS Analysis of Illicit and Pain Management Drugs, Including Their Metabolites, in Urine, in","author":"Stone","year":"2013"},{"issue":"Suppl 1","key":"10.1016\/j.forc.2023.100475_b0155","first-page":"S49","article-title":"Limit of blank, limit of detection and limit of quantitation","volume":"29","author":"Armbruster","year":"2008","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.forc.2023.100475_b0160","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.drugalcdep.2018.06.020","article-title":"Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting","volume":"190","author":"Tupper","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forc.2023.100475_b0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12954-018-0252-8","article-title":"Evaluation of a fentanyl drug checking service for clients of a supervised injection facility","volume":"15","author":"Karamouzian","year":"2018","journal-title":"Vancouver, Canada, Harm Reduction Journal"},{"key":"10.1016\/j.forc.2023.100475_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103169","article-title":"An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods","volume":"93","author":"Laing","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.forc.2023.100475_b0175","doi-asserted-by":"crossref","first-page":"108300","DOI":"10.1016\/j.drugalcdep.2020.108300","article-title":"Drug checking identifies counterfeit alprazolam tablets","volume":"218","author":"Tobias","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forc.2023.100475_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103611","article-title":"Rapid and accurate etizolam detection using surface-enhanced Raman spectroscopy for community drug checking","volume":"102","author":"Gozdzialski","year":"2022","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.forc.2023.100475_b0185","unstructured":"2019 National Drug Threat Assessment in, United States Drug Enforcement Agency, Springfield, VA, 2019."},{"key":"10.1016\/j.forc.2023.100475_b0190","unstructured":"2017 National Drug Threat Assessment in, United States Drug Enforcement Agency, Springfield, VA, 2017."},{"key":"10.1016\/j.forc.2023.100475_b0195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12954-021-00478-4","article-title":"High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips","volume":"18","author":"Lockwood","year":"2021","journal-title":"Harm Reduct. J."},{"issue":"70","key":"10.1016\/j.forc.2023.100475_b0200","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.15585\/mmwr.mm7034a4","article-title":"Notes from the Field: Illicit Benzodiazepines Detected in Patients Evaluated in Emergency Departments for Suspected Opioid Overdose \u2014 Four States, October 6, 2020\u2013March 9, 2021","volume":"2021","author":"Aldy","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.forc.2023.100475_b0205","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2105\/AJPH.2022.306881","article-title":"Xylazine and Overdoses: Trends, Concerns, and Recommendations","volume":"112","author":"Alexander","year":"2022","journal-title":"Am. J. Public Health"}],"container-title":["Forensic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468170923000115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468170923000115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T05:10:09Z","timestamp":1762837809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468170923000115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":41,"alternative-id":["S2468170923000115"],"URL":"https:\/\/doi.org\/10.1016\/j.forc.2023.100475","relation":{},"ISSN":["2468-1709"],"issn-type":[{"value":"2468-1709","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validated method for the analysis of 22 illicit drugs and their metabolites via liquid chromatography tandem mass spectrometry (LC-MS\/MS) in illicit drug samples collected in Chicago, IL","name":"articletitle","label":"Article Title"},{"value":"Forensic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forc.2023.100475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100475"}}